Anika to Present at the 2017 Canaccord Genuity Musculoskeletal Conference on March 14, 2017
February 28 2017 - 4:05PM
Business Wire
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated
orthopedic medicines company specializing in therapeutics based on
its proprietary hyaluronic acid (“HA”) technology, today announced
that its President and Chief Executive Officer, Charles H.
Sherwood, Ph.D., will make a presentation at the 2017 Canaccord
Genuity Musculoskeletal Conference on Tuesday, March 14, 2017 at
10:00 am PT. The conference is being held at the Westin San Diego
hotel.
A live audio webcast of the presentation may be accessed via the
“Investor Relations” section of Anika’s website at
www.anikatherapeutics.com. An audio archive of the presentation
also will be available on the website.
About Anika Therapeutics, Inc.Anika Therapeutics,
Inc. (NASDAQ: ANIK) is a global, integrated orthopedic
medicines company based in Bedford, Massachusetts. Anika
is committed to improving the lives of patients with degenerative
orthopedic diseases and traumatic conditions with clinically
meaningful therapies along the continuum of care, from palliative
pain management to regenerative cartilage repair. The Company has
over two decades of global expertise developing, manufacturing, and
commercializing more than 20 products based on its
proprietary hyaluronic acid (HA) technology. Anika's
orthopedic medicine portfolio includes ORTHOVISC®, MONOVISC®, and
CINGAL®, which alleviate pain and restore joint function by
replenishing depleted HA, and HYALOFAST®, a solid HA-based scaffold
to aid cartilage repair and regeneration. For more information
about Anika, please visit www.anikatherapeutics.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170228005073/en/
For Investor Inquiries:Anika Therapeutics, Inc.Sylvia Cheung,
781-457-9000Chief Financial OfficerorFor Media Inquiries:Pure
Communications, Inc.Katie Engleman, 910-509-3977
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024